Mitoxantrone drug users more likely to develop colorectal cancer

[News]

The multiple sclerosis (MS) drug mitoxantrone may be associated with an increased risk of colorectal cancer, according to a study published in the May 11, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. Mitoxantrone suppresses the immune system.

More... (http://www.news-medical.net/news/20160512/Mitoxantrone-drug-users-more-likely-to-develop-colorectal-cancer.aspx)